Rhumbline Advisers Decreases Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Rhumbline Advisers trimmed its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.0% during the 1st quarter, Holdings Channel reports. The institutional investor owned 265,244 shares of the biotechnology company’s stock after selling 2,689 shares during the quarter. Rhumbline Advisers’ holdings in Sarepta Therapeutics were worth $16,928,000 at the end of […]
Rhumbline Advisers trimmed its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.0% during the 1st quarter, Holdings Channel reports. The institutional investor owned 265,244 shares of the biotechnology company’s stock after selling 2,689 shares during the quarter. Rhumbline Advisers’ holdings in Sarepta Therapeutics were worth $16,928,000 at the end of […]
